Page last updated: 2024-08-24

nelfinavir and thiourea

nelfinavir has been researched along with thiourea in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bogaerts, E; Coucke, C; Devisscher, L; Geerts, A; Laukens, D; Libbrecht, L; Paridaens, A; Raevens, S; Van Steenkiste, C; Van Vlierberghe, H; Vandewynckel, YP; Vandierendonck, A; Verhelst, X	1

Other Studies

1 other study(ies) available for nelfinavir and thiourea

Article	Year
Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma. Oncotarget, 2016, Jun-07, Volume: 7, Issue:23 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Cinnamates; Drug Synergism; Endoplasmic Reticulum Stress; Humans; Liver Neoplasms; Mice; Nelfinavir; Oligopeptides; Proteasome Inhibitors; Thiourea; Tunicamycin; Unfolded Protein Response; Xenograft Model Antitumor Assays	2016

Article

Year

Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma.

Oncotarget, 2016, Jun-07, Volume: 7, Issue:23

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Cinnamates; Drug Synergism; Endoplasmic Reticulum Stress; Humans; Liver Neoplasms; Mice; Nelfinavir; Oligopeptides; Proteasome Inhibitors; Thiourea; Tunicamycin; Unfolded Protein Response; Xenograft Model Antitumor Assays

2016